DME supplier asked to return $8 million for faulty claims for test strips, lancets
A new Office of Inspector General report recommends that iCare refund Medicare more than $8 million for improperly filing claims for test strips and lancets.
NCPA hails stimulus package tax breaks
National Community Pharmacists Association applauded tax breaks in the economic stimulus bill that would help community pharmacies.
Universal American, CVS Caremark end partnership
Universal American and CVS Caremark end alliance in the Prescription Pathway Medicare Part D drug plan.
Hutchinson leaves SureScripts for Prematics
Prematics names Kevin Hutchinson as its new CEO.
Express Scripts report finds that drug spending rose in 2006
More people are taking medications than ever before, according to a new Express Scripts report.
Fentanyl patches being recalled due to tear
Certain fentanyl patches are being recalled because they have a cut exposing the opioid inside.
Severe reactions in patients bolused with Baxter's heparin
Heparin multi-dose vials associated with allergic reactions.
Some suncreens hurt coral reefs, warns biochemist
When purchasing sunscreens, consumers should pick biodegradable ones that don't hurt coral reefs, urges a Florida biochemist.
Four more companies to gain URAC accreditation
URAC is poised to grant accreditation to four companies for their pharmacy benefit management and/or drug therapy management programs.
New Philadelphia PBM seeking pharmacists for growth
FutureScripts, a new pharmacy benefit manager in Philadelphia, is on the growth track
Feds propose new rules to ensure patient safety
The Agency for Healthcare Research and Quality has proposed new rules for implementing the Patient Safety Act.
Good Neighbor endows chair at University of the Pacific
Good Neighbor Pharmacy will endow a chair in entrepreneurial pharmacy practice at the University of the Pacific in California.
ENHANCE study to affect utilization, not coverage, of cholesterol-lowering drugs
A survey of pharmacists and physicians at managed care companies finds that they believe Vytorin use will drop but coverage will remain the same.
Florida judge opens up access to Mylan's generic levothyroxine
Mylan's generic levothyroxine removed from Florida's negative formulary.
Heat therapy products recalled for causing burns
Chattem's Icy Hot Heat Therapy products have been linked to burns and are being recalled
Anti-leukemia drug increases fatigue in pediatric patients
Dexamethasone increases fatigue in children; altering dosing could improve quality of life for patients and their families.
ASCO issues VTE guide specific to cancer patients
ASCO has updated its guidelines on deep vein thrombosis.
MRSA'S MERCILESS MARCH
Antibiotic-resistant germ forcing hospitals, community to seek new ways to control infection.
NHIA's new leader talks about the challenges facing the home infusion industry
NHIA's new executive director Russell Bodoff talks to Drug Topics about his organization's goals.
Consumers can get their ZZZs with these sleeping aids
New over the counter sleep aids.
Get ready to provide patients with a toll-free number for reporting adverse events
What pharmacists need to know about FDA's toll free number for reporting adverse events rule.
Innovative MTM programs are on the rise
Pharmacists push innovative medication therapy management models.
FDA's crackdown on bio-identical hormones sparks controversy
Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.
NCPDP group racing to recommed tamper-resistant pad rules
April 1 is the deadline for all Medicaid prescriptions to be written on tamper-resistant Rx pads.
Letters: February 11, 2008
Pharmacists speak out about a behind-the-counter class of drugs, pharmacy coupons, and Mevacor going OTC.
Latebreakers: FDA's decision on cough and cold OTCs for kids draws support
Industry supports FDAs decision against OTC cough and cold medicines for children under two
Latebreakers: Antifungal approved for new indication
Mycamine from Astellas Pharma was given a supplemental indication approval
Latebreakers: New recombinant injection approved for growth failure
Sandoz's Omnitrope Pen 5 has been cleared for treating kids with growth failure and adults with growth hormone deficiency on a long-term basis
Latebreakers: Welchol granted approved
Colesevelam approved for new indication
